145 related articles for article (PubMed ID: 34280845)
21. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
22. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
23. Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma.
Murray SE; Schneider DF; Bauer PS; Sippel RS; Chen H
J Am Coll Surg; 2013 Jun; 216(6):1174-80. PubMed ID: 23522438
[TBL] [Abstract][Full Text] [Related]
24. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.
Xu L; Port M; Landi S; Gemignani F; Cipollini M; Elisei R; Goudeva L; Müller JA; Nerlich K; Pellegrini G; Reiners C; Romei C; Schwab R; Abend M; Sturgis EM
Thyroid; 2014 Jun; 24(6):966-74. PubMed ID: 24555500
[TBL] [Abstract][Full Text] [Related]
25. Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database.
Oakley GM; Curtin K; Pimentel R; Buchmann L; Hunt J
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1171-4. PubMed ID: 24092278
[TBL] [Abstract][Full Text] [Related]
26. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
27. Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.
Bogdanova TI; Saenko VA; Hashimoto Y; Hirokawa M; Zurnadzhy LY; Hayashi T; Ito M; Iwadate M; Mitsutake N; Rogounovitch TI; Sakamoto A; Naganuma H; Miyauchi A; Tronko MD; Thomas G; Yamashita S; Suzuki S
Thyroid; 2021 Sep; 31(9):1322-1334. PubMed ID: 33143557
[No Abstract] [Full Text] [Related]
28. Multiple primary breast and thyroid cancer.
Ron E; Curtis R; Hoffman DA; Flannery JT
Br J Cancer; 1984 Jan; 49(1):87-92. PubMed ID: 6691901
[TBL] [Abstract][Full Text] [Related]
29. Nodule Size Effect on Diagnostic Performance of Ultrasonography and Computed Tomography for Papillary Thyroid Carcinoma.
Li JW; Chang C; Chen JY; Shi ZT; Chen M
Curr Med Imaging Rev; 2019; 15(5):489-495. PubMed ID: 32008556
[TBL] [Abstract][Full Text] [Related]
30. Association between the increase in incidence of papillary thyroid carcinoma in Crete and exposure to radioactive agents.
Prokopakis EP; Kaprana A; Karatzanis A; Velegrakis GA; Melissas J; Chalkiadakis G
Acta Otorhinolaryngol Ital; 2018 Aug; 38(4):310-315. PubMed ID: 29498716
[TBL] [Abstract][Full Text] [Related]
31. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
32. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
[No Abstract] [Full Text] [Related]
33. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
34. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.
Schonfeld SJ; Curtis RE; Anderson WF; Berrington de González A
Cancer Causes Control; 2012 Oct; 23(10):1721-8. PubMed ID: 22918549
[TBL] [Abstract][Full Text] [Related]
35. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
[TBL] [Abstract][Full Text] [Related]
36. Understanding the natural history of papillary thyroid cancer: Case series.
Lin JK; Sakoda LC; Darbinian J; Chiao W; Calixto N; Gurushanthaiah D; Wang KH; Durr M
Head Neck; 2019 Dec; 41(12):4164-4170. PubMed ID: 31584743
[TBL] [Abstract][Full Text] [Related]
37. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
[TBL] [Abstract][Full Text] [Related]
38. Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients.
Siraj AK; Poyil PK; Parvathareddy SK; Alobaisi K; Ahmed SO; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360599
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
40. Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018.
Megwalu UC; Moon PK
Thyroid; 2022 May; 32(5):560-570. PubMed ID: 35132899
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
